UnitedHealth Group CEO says complex US healthcare system needs to change
UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...
UnitedHealth Group CEO: U.S. Health System Needs To Function Better
In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...
Medscape3d
Doxycycline Postexposure Prophylaxis Cuts STIs in At-Risk Groups
Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...
Benefits Pro10h
Ozempic among 15 drugs selected for Medicare drug price talks, Round 2, with Big Pharma
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?
We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...
Kepler Capital Keeps Their Hold Rating on GlaxoSmithKline (GSK)
In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...
FDA adds warning label to RSV vaccines Abrysvo and Arexvy about the risk for Guillain-Barré syndrome
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...
healthday on MSN3d
FDA Adds Warning Label to RSV Vaccines Abrysvo and Arexvy
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing informa ...
Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?
We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are ...
The Lancet3d
The time for regionalised vaccine manufacturing has arrived
The current approach to global vaccine research and development (R&D), manufacturing, and distribution has greatly expanded routine immunisation, achieving substantial reductions in disease burden ...